The Tencent and Legend-backed company, which claims to be China's largest mobile game publisher, will earmark some of the proceeds for acquisitions.

The deal provided exits for NetDragon, which received over $1bn in the deal, and IDG Capital Partners.

$35m is to be paid upfront, with a further $40m depending on future milestones.

The biopharmaceutical company exceeds expectations by selling shares at $17 each.

Qualcomm Atheros, an investor since 2008, has acquired chipmaker Wilocity in a deal through that enabled backers including Marvell Technology to exit.

The pharmaceutical company raised $32.7m after floating at a price far below its range, while Janssen Pharmaceutica took a 17% stake.

Intel Capital, Imagination Technologies' largest shareholder, has cut its share from 14% to 5%, causing the microchip maker's stock to fall.

Music streaming service Rdio has acquired competitor TastemakerX, enabling an exit for investors including AOL Ventures.

Array Biopharma is among the shareholders of the cancer therapeutics developer after striking a development deal in July last year.